Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3021197	s-mg-ion	mmol/l (—)	1641	4651	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

396

444

9.12

321.81

4.1

2.3

—

ILD medications: azathioprine

227

24.40

319.15

3.0

1.7

—

First line medication for Crohn's disease

724

650

6.12

317.24

3.4

2.0

—

Nephropathy related operations

624

109

65.56

307.65

3.9

1.9

—

ILD medications: prednisolone, methylprednisolone, prednisone

777

647

6.85

307.65

3.5

1.9

—

L04AD Calcineurin inhibitors

657

96.93

307.65

4.2

1.6

—

Extracorporeal dialysis

296

48.04

307.65

3.0

2.5

—

Renal tubulo-interstitial diseases

807

702

8.94

307.65

3.0

2.8

—

Chronic periodontitis

343

119

30.42

307.65

3.6

2.0

—

ILD medications

781

648

6.67

307.65

3.5

1.9

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

191

63.28

307.65

4.4

2.2

—

Care involving dialysis

439

75.18

307.65

3.1

2.7

—

Kidney transplant status

368

94.50

307.65

3.5

2.6

—

Glomerular diseases

396

200

20.82

307.65

2.8

2.6

—

Dialysis, with operation codes

649

81.53

307.65

3.8

2.1

—

Persons encountering health services for specific procedures and health care

739

768

6.01

307.65

3.0

2.7

—

Heart failure, not strict

683

581

8.23

307.65

3.3

2.6

—

Transplanted organ and tissue status

649

117.98

307.65

4.2

1.8

—

Direct fill therapy

312

150

21.94

307.65

4.1

2.5

—

Dental caries

539

193

28.83

307.65

3.8

2.1

—

Dialysis

182

86.29

307.65

3.2

2.7

—

Chronic kidney disease

662

242

28.61

307.65

3.0

2.5

—

Glomerular disorders in diseases classified elsewhere

300

117

27.35

307.65

2.8

2.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

788

696

7.78

307.65

3.7

2.0

—

L04AA Selective immunosuppressants

615

204

32.14

307.65

3.9

1.9

—

Dentinal caries

474

168

29.28

307.65

3.8

2.1

—

Secondary hypertension

194

63.48

307.65

3.1

2.8

—

ILD medications: immunosuppressive drugs

796

566

13.78

307.65

3.8

1.9

—

Renal failure

743

352

19.97

307.65

3.0

2.5

—

Preparatory care for dialysis

318

108.99

307.65

3.0

2.5

—

Acute renal failure

279

170

16.93

307.65

3.0

2.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

272

186

15.31

307.03

4.3

2.3

—

Malignant neoplasm of oral cavity

173

51.81

297.49

4.6

2.3

—

Chronic periapical parodontitis

253

161

16.12

295.82

3.9

2.0

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

214

102

22.08

287.42

4.1

2.5

—

Diseases of pulp and periapical tissues

317

316

10.19

280.89

3.7

2.1

—

Malignant neoplasm of head and neck

202

22.90

274.49

4.2

2.4

—

Deposits [accretions] on teeth

169

42.18

272.65

4.4

2.4

—

Fibrosis and cirrhosis of liver

189

25.95

269.43

4.1

1.9

—

Other disorders of teeth and supporting structures

231

155

15.24

262.49

4.2

2.0

—

Anaemias

241

26.27

256.80

3.6

1.6

—

Implicit Sepsis

515

708

5.71

249.76

3.0

2.6

—

Oesophageal varices

147

46.60

248.24

4.9

2.7

—

Azathioprine

227

167

14.01

245.34

3.0

2.8

—

Explicit Sepsis

346

429

7.84

245.29

3.3

2.5

—

Bacterial Sepsis

370

443

7.54

245.25

3.0

2.6

—

Implicit bacterial Sepsis

335

374

8.34

244.61

3.0

2.5

—

Missing teeth due to accident, extraction or parodontitis

183

21.34

243.33

4.5

2.0

—

Chronic periodontitis, complicated

199

118

17.80

242.20

3.5

2.6

—

Other bacterial diseases

616

878

4.89

242.08

3.1

2.7

—

Unspecified kidney failure

160

29.23

239.37

3.2

2.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

620

945

4.74

238.73

3.0

2.7

—

Septicaemia

342

434

7.69

238.67

3.3

2.4

—

Bacterial infection, other or unspecified

399

551

6.61

237.03

3.1

2.6

—

Other septicaemia

318

386

8.21

236.55

3.2

2.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

541

774

5.12

228.08

3.1

2.7

—

Glomerulonephritis

188

115

17.09

224.99

2.9

2.8

—

Disorders resulting from impaired renal tubular function

135

38.70

217.03

3.5

2.6

—

Other dialysis

125

44.18

207.71

3.2

3.1

—

Fever of other and unknown origin

380

622

5.72

198.15

3.2

2.6

—

Cystic kidney disease

118

40.84

192.73

3.1

2.8

—

Cholangitis (primary sclerosing, PSC)

136

23.98

188.62

4.4

2.5

—

Hypertensive diseases (excluding secondary)

353

278

7.45

187.60

3.2

2.6

—

Cirrhosis of liver, NAS

129

27.23

186.85

4.8

2.3

—

Tramadol

488

656

4.82

183.31

3.3

2.7

—

Congenital malformations of the urinary system

132

23.69

182.13

3.1

2.4

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

101

59.47

179.37

4.0

2.3

—

Implicit viral Sepsis

192

185

10.60

174.53

3.4

2.6

—

Viral Sepsis

192

185

10.59

174.53

3.4

2.6

—

Hepatic failure, not elsewhere classified

112

33.95

174.00

4.0

2.0

—

Diabetic nephropathy, excluding more controls

205

161

10.98

172.41

2.6

2.9

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

70.63

170.07

4.1

2.3

—

Hypertensive diseases

461

529

4.97

169.13

3.2

2.7

—

Hypertension

460

528

4.97

168.66

3.2

2.7

—

Any gastric operation

376

287

6.61

168.22

2.9

1.6

—

GASTRO-related operations

376

287

6.61

168.22

2.9

1.6

—

Diabetic nephropathy

207

229

9.22

167.74

2.6

3.0

—

Nephrotic syndrome

100

43.69

166.44

2.7

3.3

—

Alcoholic liver disease

149

109

14.18

161.75

4.5

2.2

—

Malignant neoplasm of tongue

48.42

155.67

3.9

2.4

—

Other diseases of hard tissues of teeth

338

464

5.47

154.74

3.7

2.1

—

Ascites

123

18.88

154.54

4.5

2.4

—

Disorders of parathyroid gland

197

227

8.74

154.31

2.8

2.4

—

Malignant neoplasm of other and unspecified parts of tongue

66.66

149.45

3.8

1.9

—

Autoimmune diseases excluding thyroid diseases, strict definition

544

801

3.81

145.58

3.0

2.7

—

Care involving use of rehabilitation procedures

333

660

4.83

145.38

2.8

2.7

—

Other disorders of kidney and ureter

165

167

10.18

145.15

3.3

2.6

—

Hernia of abdominal wall, postoperative

129

14.87

145.10

3.4

1.7

—

Hyperparathyroidism

179

198

9.12

144.96

2.7

2.4

—

Autoimmune diseases excluding thyroid diseases

555

830

3.73

144.53

3.0

2.6

—

Aplastic and other anaemias

302

553

5.24

144.34

3.3

2.4

—

Acute tubulo-interstitial nephritis

304

517

5.25

142.79

3.0

2.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

102

23.12

139.91

4.1

2.2

—

Other diseases of lip and oral mucosa

139

115

12.31

139.73

4.0

2.0

—

Cardiovascular diseases (excluding rheumatic etc)

328

334

5.71

139.44

3.2

2.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

269

258

6.67

137.34

3.6

2.6

—

Parodontitis or operation codes

495

1012

3.63

137.20

3.3

2.7

—

Chronic periodontitis, including avohilmo

492

1013

3.62

136.09

3.3

2.7

—

Parodontitis

492

1014

3.60

135.00

3.3

2.7

—

Infections, IBD-co-morbidities

161

104

11.46

129.41

3.8

2.5

—

Need for immunization against other single viral diseases

44.67

126.65

2.9

3.0

—

Examination and observation for other reasons

339

441

4.71

121.44

2.9

2.4

—

Parodontitis and operation codes

457

1032

3.47

120.61

3.3

2.7

—

Hypertension, essential

386

520

4.26

120.20

3.2

2.7

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

41.43

119.96

4.5

2.0

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

27.22

119.93

3.1

2.6

—

Other heart diseases

249

274

6.04

119.17

2.9

2.6

—

Other and unspecified anaemias

258

502

5.02

118.65

3.2

2.4

—

Other disorders involving the immune mechanism, not elsewhere classified

25.50

117.26

3.1

2.5

—

Other anaemias

258

507

4.96

116.83

3.2

2.4

—

Gingivitis and periodontal diseases

391

482

4.21

115.01

2.8

2.0

—

IgA nephropathy (IgA glomerulonephritis)

30.10

114.89

3.1

2.9

—

Diseases of oral cavity, salivary glands and jaws

392

487

4.15

113.08

2.9

2.0

—

Complications of surgical and medical care, not elsewhere classified

487

1086

3.23

112.87

3.1

2.7

—

Other diseases of liver

155

201

7.85

112.03

4.1

2.2

—

Heart failure and antihypertensive medication

173

131

8.83

111.62

2.5

2.7

—

Acute peritonitis

15.13

111.35

3.4

2.5

—

Other diseases of biliary tract

106

13.32

111.24

4.8

2.4

—

Insulin medication

352

789

3.84

111.11

3.3

2.7

—

Insulin, combination of fast acting with intermediate-acting or long-acting

352

865

3.78

110.96

3.3

2.6

—

Certain infectious and parasitic diseases

441

593

3.74

110.73

2.9

2.6

—

Cytomegaloviral disease

33.72

109.87

4.6

2.8

—

Cytomegalovirus infection, IBD co-morbidity

34.87

109.36

4.6

2.6

—

Influenza and pneumonia

504

1058

3.15

108.96

2.9

2.8

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

37.75

108.43

5.0

2.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

431

784

3.46

106.10

2.8

2.9

—

431

784

3.46

106.10

2.8

2.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

153

201

7.50

104.80

3.2

2.8

—

General symptoms and signs

499

765

3.28

104.61

3.0

2.7

—

Pneumonias (Asthma/COPD co-morbidities)

475

1052

3.14

104.21

2.8

—

Primary biliary cholangitis (PBC)

44.76

103.69

3.4

1.6

—

Failure and rejection of transplanted organs and tissues

52.88

103.48

4.2

3.9

—

Disorders of other endocrine glands

256

567

4.48

103.33

2.8

2.6

—

Other disorders of fluid, electrolyte and acid-base balance

198

344

5.62

102.89

3.1

2.8

—

Malignant neoplasm of liver and intrahepatic bile ducts

22.52

102.41

4.7

2.1

—

Metabolic disorders

469

915

3.20

102.23

2.8

3.0

—

Insulin, fast-acting

236

504

4.73

102.18

3.4

2.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

164

145

7.99

101.68

2.9

2.7

—

Chronic nephritic syndrome

20.52

101.43

3.1

2.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

17.77

101.07

4.5

2.2

—

All pneumoniae

480

1088

3.06

100.65

2.8

2.9

—

Colitis, primary sclerosing

45.25

99.99

4.8

2.3

—

Other/unspecified cytomegaloviral diseases

37.30

97.03

4.7

2.8

—

Any reimbursement code in KELA

212

158

6.75

96.69

2.9

1.5

—

Autoimmune diseases

500

833

3.08

95.74

3.0

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

355

953

3.40

95.62

3.0

2.7

—

Insulin, fast-acting or short human

239

546

4.42

95.17

3.3

2.5

—

Heart failure,strict

249

392

4.62

93.74

2.4

2.5

—

Antihypertensive medication - note that there are other indications

254

277

5.04

93.57

2.9

2.2

—

Intestinal infectious diseases

440

1140

3.02

93.45

3.1

2.7

—

Pneumonia, organism unspecified

427

998

3.11

93.35

2.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

461

1094

2.98

92.77

2.8

2.9

—

Insulin, intermediate and long-acting

298

805

3.66

91.26

3.1

2.6

—

Genitourinary diseases

273

289

4.76

90.94

2.9

3.3

—

Type 1 diabetes

179

334

5.41

90.59

3.0

2.6

—

Oxycodone

195

378

5.03

90.12

3.4

2.6

—

Ulcer of lower limb, not elsewhere classified

123

158

7.94

89.69

2.7

2.6

—

Gingival hyperplasia

40.31

88.35

3.4

2.4

—

Cardiovascular diseases

251

287

4.79

87.51

3.1

2.4

—

Hepatocellular carcinoma

29.21

87.13

4.9

1.8

—

Diseases of the digestive system

254

649

3.94

86.84

3.5

2.5

—

Colitis, primary sclerosing, strict definition

48.76

86.25

4.8

1.9

—

Bleeding

400

953

3.07

85.77

3.2

2.7

—

Chronic hepatitis, not elsewhere classified

19.60

85.30

4.5

2.1

—

Used for control exclusion in common control thyroid runs

462

784

3.00

84.73

2.9

2.7

—

Diseases of peritoneum

106

123

8.82

84.08

3.4

2.5

—

Opioids

423

716

3.11

83.48

2.9

2.7

—

Inflammatory bowel disease treatment related agents

506

1054

2.74

82.51

2.8

—

Gastrointestinal diseases

215

198

5.46

82.07

2.7

1.6

—

Disorders of gallbladder, biliary tract and pancreas

449

1027

2.83

80.81

3.2

2.8

—

Gout

183

345

4.89

80.07

2.9

2.7

—

Other disorders of gingiva or/and edentulous alveolar ridge

21.31

79.73

3.3

2.6

—

Gout, FINNGEN

183

390

4.75

79.68

2.9

2.5

—

Nausea and vomiting

148

257

5.71

79.17

3.4

2.3

—

Hypertensive Renal Disease

33.03

79.05

2.7

2.4

—

Second line medication for Crohn's disease

293

880

3.35

78.99

2.8

—

L04AX Other immunosuppressants

288

856

3.39

78.95

2.8

—

Other disorders of skin and subcutaneous tissue

324

942

3.17

78.09

3.0

2.7

—

Hypertensive heart and/or renal disease

142

172

6.46

77.79

2.5

2.7

—

Malaise and fatigue

227

469

4.06

76.85

3.2

2.6

—

Other diseases of the digestive system

193

443

4.40

76.58

3.5

2.5

—

Other inflammatory liver diseases

12.18

76.56

3.9

2.0

—

Hyperkalaemia

16.34

76.33

3.0

2.3

—

Complications of procedures, not elsewhere classified

356

1051

2.94

74.46

3.0

2.7

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

472

1010

2.67

73.89

3.0

2.8

—

GI-bleeding

188

437

4.34

73.40

3.5

2.5

—

Oedema, not elsewhere classified

163

336

4.87

73.23

2.9

2.8

—

IBD (strict) with PSC

41.62

71.56

5.1

2.0

—

Sub-endpoint used in defining T1D endpoints

182

418

4.32

70.30

3.0

2.5

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

203

386

4.13

68.79

2.9

2.3

—

Type 2 diabetes, wide definition

364

823

2.90

68.60

2.9

2.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

375

774

2.88

67.75

2.9

2.7

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

375

774

2.88

67.74

2.9

2.7

—

Diseases of oesophagus, stomach and duodenum

452

1066

2.59

67.69

3.2

2.7

—

Malignant neoplasm, wide definition for exclusion

375

775

2.87

67.59

2.9

2.7

—

Complications of medical and surgical care

328

1090

2.87

67.27

2.9

2.8

—

Medical observation and evaluation for suspected diseases and conditions

296

444

3.43

66.97

3.3

2.3

—

Endocrine, nutritional and metabolic diseases

324

517

3.20

66.10

3.0

2.8

—

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

110.80

65.93

5.9

2.6

—

Gout, idiopatic and unspecified

154

337

4.63

65.04

2.8

2.5

—

Symptoms and signs involving the digestive system and abdomen

412

757

2.74

64.57

2.9

2.6

—

Any event in cancer register

382

824

2.76

64.29

2.9

2.7

—

Calculus of kidney and ureter

183

461

4.01

64.29

2.0

2.8

—

Persons encountering health services in other circumstances, wide

484

1015

2.48

63.76

3.0

2.8

—

Alcohol use disorder, Swedish definition

279

852

3.06

63.64

3.5

2.6

—

Urolithiasis

190

498

3.85

63.13

2.0

2.7

—

134

7.11

62.57

3.1

2.4

—

Certain disorders involving the immune mechanism

131

260

5.10

62.17

2.8

2.7

—

Type 1 diabetes, wide definition, subgroup 1

127

246

5.21

61.81

3.1

2.4

—

Autoimmune diseases related-to ILD

367

1241

2.61

61.80

3.1

2.7

—

Benign neoplasm: Colon

204

413

3.81

61.79

2.9

2.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

270

903

3.00

60.46

2.9

2.8

—

Malignant neoplasm

370

815

2.70

59.99

2.9

2.7

—

Type 1 diabetes, wide definition

134

279

4.84

59.98

3.1

2.4

—

Gout, unspecified

129

261

5.01

59.90

2.8

2.5

—

Artificial opening status

15.11

59.78

3.3

1.6

—

Diseases of arteries, arterioles and capillaries

305

794

2.88

59.32

2.8

—

Benign neoplasms

301

564

3.03

58.66

2.9

2.6

—

Parodontitis or/and operation codes

323

671

2.88

58.56

3.3

3.0

—

Unspecified jaundice

13.06

58.16

3.2

2.0

—

Benign neoplasm of colon, rectum, anus and anal canal

222

460

3.47

57.54

2.9

2.6

—

Atrial fibrillation and flutter

140

178

5.17

57.49

2.7

—

Fungal Sepsis

15.11

57.29

3.5

3.0

—

Cerebrovascular diseases (FINNGEN)

136

193

5.07

56.96

2.5

2.7

—

Noninfective enteritis and colitis

226

708

3.21

56.96

3.4

2.7

—

Melanocytic naevi of trunk

103

7.78

56.91

3.1

2.6

—

279

898

2.87

56.76

3.5

2.6

—

287

912

2.83

56.76

3.5

2.6

—

Erysipelas

226

640

3.24

56.62

2.8

2.7

—

Nutritional anaemias

215

637

3.30

56.49

3.1

2.6

—

Filling of root of tooth

14.30

56.48

4.2

2.7

—

Heart failure, strict

261

614

3.08

56.26

2.5

2.8

—

Osteopathies and chondropathies

252

801

3.00

56.01

3.2

2.6

—

Chronic tubulo-interstitial nephritis

20.07

55.61

2.9

2.8

—

Melanocytic naevi

134

301

4.49

54.77

2.8

2.5

—

Other heart diseases, wide

375

920

2.54

54.61

2.9

3.0

—

Other diseases of intestines

419

1008

2.42

54.52

3.1

2.8

—

Neoplasms

293

530

2.97

54.36

3.0

2.6

—

Gout, strict definition

114

227

5.09

53.97

2.8

2.6

—

Implicit fungal Sepsis

15.10

53.87

3.1

2.9

—

Osteoporosis

133

284

4.51

53.81

3.7

2.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

392

1058

2.42

52.53

3.4

2.6

—

Diabetes, varying definitions

402

997

2.42

52.44

3.2

2.7

—

Paralytic ileus and intestinal obstruction

133

309

4.34

52.08

3.0

2.6

—

Other medical care

152

379

3.94

52.06

2.9

2.5

—

Other viral diseases

155

403

3.87

51.92

3.7

2.7

—

All-cause Heart Failure

247

596

3.00

51.19

2.5

2.8

—

Continuous positive airway pressure

107

175

5.32

50.72

2.3

3.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

380

956

2.44

50.72

3.2

2.8

—

COPD/asthma related infections

388

785

2.48

50.71

2.6

2.9

—

COPD/asthma/ILD related infections

388

785

2.48

50.71

2.6

2.9

—

Iron deficiency anaemia

185

549

3.36

50.19

3.3

2.6

—

Disorders of lens

312

743

2.66

50.12

3.3

2.8

—

Diabetes mellitus

398

1004

2.37

49.94

3.1

2.8

—

Ulcerative colitis (strict) with PSC

35.79

49.84

5.1

2.2

—

Coagulation defects, purpura and other haemorrhagic conditions

113

240

4.76

49.58

2.7

—

Viral infections characterized by skin and mucous membrane lesions

198

627

3.18

49.17

3.3

2.7

—

Disorders of mineral metabolism

8.00

48.59

2.9

2.8

—

Anaemia in chronic diseases classified elsewhere

18.54

48.36

3.8

2.4

—

Intestinal stricture

157

435

3.64

48.24

2.9

2.5

—

Budesonide

140

6.07

48.18

3.4

2.7

—

Crohn disease

168

5.55

48.00

3.6

2.9

—

Hypothyroidism (congenital or acquired)

7.72

47.61

2.7

1.6

—

Other gastritis (incl. Duodenitis)

126

303

4.20

47.26

3.6

2.5

—

Bronchitis

405

1174

2.27

47.20

2.7

2.9

—

Other Crohn's disease

8.61

46.87

3.6

3.0

—

Polyarthropathies

309

811

2.55

46.45

2.8

2.9

—

Peripheral artery disease

196

498

3.19

46.33

2.5

2.6

—

Peripheral artery operations in Hilmo

149

5.77

46.28

2.6

2.8

—

Inflammatory bowel disease

165

486

3.42

46.19

3.6

2.8

—

Hypothyroidism and >3 levothyroxin purchases

7.55

45.82

2.7

1.6

—

Hypothyroidism, levothyroxine purchases

7.55

45.82

2.7

1.6

—

Oral leukoplakia and related diseases, including avohilmo

121

6.40

45.73

4.3

2.7

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

240

881

2.74

45.72

2.7

—

Disorders of calcium metabolism

10.62

45.60

3.1

2.1

—

Congenital malformations, deformations and chromosomal abnormalities

243

860

2.72

45.33

3.2

2.8

—

Amputation of toe

7.91

45.16

2.6

2.4

—

Opening and dilatation of root channel of tooth

8.36

44.99

4.1

2.7

—

Diabetes, insulin treatment (Kela reimbursement)

388

1044

2.28

44.94

3.1

2.8

—

Mucosal proctocolitis

169

5.33

44.52

3.9

3.0

—

Other bacterial intestinal infections

100

210

4.81

44.51

3.3

2.7

—

Erosion of teeth, including avohilmo

131

5.94

44.48

3.4

2.0

—

Explicit bacterial Sepsis

7.45

44.48

3.5

2.6

—

Disorders of tooth development and eruption

18.72

44.47

2.5

2.9

—

Ulcerative colitis

133

348

3.85

44.46

3.7

2.7

—

Oral leukoplakia and related diseases

8.70

43.95

4.7

2.2

—

Statin medication

278

584

2.68

43.77

3.0

—

Diabetes medication

387

1045

2.26

43.75

3.2

2.7

—

Congenital malformations of gallbladder, bile ducts and liver

31.73

43.66

5.4

3.0

—

Abdominal and pelvic pain

359

757

2.39

43.59

2.9

2.6

—

Amputation

117

6.33

43.58

2.8

2.9

—

Viral warts

114

6.41

43.51

3.4

2.5

—

Haemolytic anaemias

12.33

42.97

3.2

2.6

—

Dentofacial anomalies [including malocclusion]

183

5.00

42.87

3.0

2.0

—

Viral hepatitis, IBD co-morbidity

11.45

42.27

3.2

2.2

—

Malignant neoplasm of digestive organs

168

522

3.19

41.93

3.0

2.4

—

Stomatitis and related lesions

9.06

41.61

3.6

2.2

—

Erosion of teeth

82.95

41.52

4.0

1.3

—

IBD patients in KELA-register

123

320

3.88

41.48

3.6

2.6

—

Melanocytic naevi of trunk

144

5.56

41.35

3.1

2.7

—

Other diseases of urinary system

382

969

2.22

40.91

2.8

—

Other and unspecified iron deficiency

140

402

3.50

40.79

3.4

2.5

—

Portal vein thrombosis

26.82

40.15

3.7

2.3

—

Benign neoplasms

375

944

2.22

40.07

2.8

—

Bacterial intestinal infections, IBD co-morbidities

100

229

4.41

40.04

3.3

2.6

—

Other or unspecified ileus, impaction or obstruction

221

4.47

39.98

2.7

2.5

—

Persons encountering health services for specific procedures, not carried out

8.37

39.84

3.2

2.8

—

Ulcerative ileocolitis

10.49

39.67

3.7

3.0

—

Type 2 diabetes

358

951

2.24

39.64

3.1

2.8

—

Other necrotizing vasculopathies

7.78

39.56

2.8

2.6

—

Drug-induced cataract

13.79

39.32

4.4

2.7

—

Covid-19 confirmed case

132

375

3.54

39.14

3.1

2.4

—

Hypothyroidism, drug reimbursement

10.02

39.12

2.0

1.8

—

Reimbursement for rheumatic diseases

232

905

2.57

39.08

3.2

2.8

—

Hydronephrosis

7.29

38.95

2.0

2.7

—

Inflammatory bowel disease, strict (require KELA)

123

335

3.70

38.87

3.6

2.7

—

Other disorders of urethra and urinary system

248

729

2.56

38.85

3.0

2.7

—

Gout due to impairment of renal function

22.55

38.60

2.8

1.7

—

Other acute lower respiratory infections

213

763

2.68

38.59

2.5

2.6

—

Acquired haemolytic anaemia

16.32

38.48

3.1

2.4

—

Chronic pancreatitis

154

5.20

38.43

3.0

2.5

—

Atherosclerosis, excluding cerebral and coronary sclerosis

173

454

3.06

38.34

2.4

2.6

—

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

71.60

38.31

5.7

2.4

—

Provisional assignment of new diseases of uncertain etiology

187

662

2.84

38.31

3.2

2.6

—

Codes for special purposes

187

663

2.83

38.20

3.2

2.6

—

Volume depletion

7.27

38.12

3.1

2.7

—

Insulin, fast-acting (human)

174

4.87

38.06

3.0

2.6

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

19.53

38.04

3.0

3.8

—

Factors influencing health status and contact with health services

109

112

4.90

37.80

2.7

1.6

—

Hypertensive Heart Disease

160

4.73

37.70

2.1

2.7

—

Melanocytic naevi

134

395

3.42

37.57

2.8

2.6

—

5-aminosalicylic acid

105

263

4.02

37.36

3.7

2.6

—

Hypokalaemia

112

5.96

37.24

3.3

2.9

—

Symptoms and signs involving the urinary system

297

1004

2.30

37.10

2.7

2.9

—

Purpura and other haemorrhagic conditions

163

4.97

36.99

2.8

—

Pain in limb

303

963

2.28

36.84

2.8

2.9

—

Crohn's disease of large intestine

8.85

36.72

3.6

3.2

—

Senile cataract

260

653

2.48

36.36

3.2

2.7

—

Constipation

326

1066

2.20

36.13

3.2

2.7

—

Malignant neoplasm of gum

104.21

36.02

5.3

2.2

—

In situ neoplasms

119

316

3.61

35.94

2.3

—

Oral corticosteroids

366

1045

2.12

35.86

2.7

2.8

—

Pain, not elsewhere classified

110

294

3.76

35.73

2.8

2.6

—

Cystitis

288

753

2.34

35.68

2.6

2.7

—

Enterocolitis due to Clostridium difficile

121

5.61

35.45

3.4

2.5

—

Benign neoplasm: Colon

205

775

2.60

35.39

2.9

2.6

—

Other infectious diseases

6.58

35.35

3.5

2.6

—

Haemorrhage from respiratory passages

144

423

3.18

35.33

2.6

2.7

—

All influenza

116

326

3.58

35.02

3.3

2.7

—

Streptococcal septicaemia

7.12

34.75

3.7

2.5

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

144

402

3.16

34.60

3.5

2.4

—

Diabetic retinopathy, excluding more controls

133

206

3.67

34.49

3.3

3.2

—

Exposure to unspecified factor

346

1291

2.09

34.27

2.8

—

Acute pancreatitis

254

3.93

34.14

3.5

2.6

—

Acute bronchitis

163

559

2.87

34.02

2.5

2.6

—

Cardiac arrhythmias

214

543

2.61

33.93

2.8

2.9

—

Ulcerative enterocolitis

10.28

33.72

3.7

3.1

—

Depression medications

6.02

33.68

2.8

1.7

—

Crohn's disease NAS

7.32

33.51

3.7

2.9

—

Infections of the skin and subcutaneous tissue

228

949

2.40

33.36

2.7

2.8

—

Mycoses

121

362

3.37

33.21

3.4

2.6

—

Benign neoplasm: Colon, unspecified

232

4.02

33.05

3.1

2.2

—

Diseases of the skin and subcutaneous tissue

353

834

2.13

33.03

2.7

2.8

—

Seborrhoeic keratosis

100

266

3.79

32.78

3.1

2.6

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

9.50

32.78

3.7

2.7

—

Disorders of lipoprotein metabolism and other lipidaemias

292

824

2.23

32.72

2.5

3.0

—

Other diseases of arteries and capillaries

102

5.86

32.71

3.3

2.7

—

Bacterial pneumonia, not elsewhere classified

150

448

2.98

32.65

2.6

—

Sequelae of external causes of morbidity and mortality

117

348

3.39

32.43

3.3

2.6

—

388

1015

2.02

32.40

2.5

2.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

226

444

2.58

32.33

3.2

2.3

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

60.07

32.12

5.2

2.4

—

Other soft tissue disorders, not elsewhere classified

337

997

2.09

32.06

2.8

2.9

—

Fentanyl

6.37

31.99

3.2

2.8

—

Excluding asthma or asthma-COPD overlap

275

591

2.34

31.97

2.5

2.9

—

Other pulmonary diagnosis

275

591

2.34

31.97

2.5

2.9

—

Other embolism and thrombosis

133

5.09

31.95

2.4

2.7

—

Glucagon-like peptide-1 (GLP-1) analogues

221

753

2.43

31.76

3.0

2.8

—

Bacterial pneumoniae

155

480

2.87

31.67

2.6

2.5

—

Isolated proteinuria

10.04

31.35

2.3

2.9

—

Abnormal findings on examination of urine, without diagnosis

8.38

31.31

2.3

2.7

—

Unspecified privation

128

5.14

31.31

2.6

2.8

—

Codeine

288

709

2.24

31.26

2.4

2.7

—

Benign neoplasm of colon, rectum, anus and anal canal

229

885

2.34

31.17

3.0

2.7

—

Acute upper respiratory infections of multiple and unspecified sites

271

919

2.22

31.10

2.7

2.9

—

Invasive ventilation

6.29

30.89

2.7

2.6

—

Other cataract

175

504

2.70

30.87

2.9

2.7

—

Other noninfective gastroenteritis and colitis

106

307

3.47

30.59

3.0

2.6

—

Ulcerative colitis, NAS

183

4.30

30.38

3.8

2.8

—

Other reaction to severe stress, and adjustment disorders

144

504

2.87

30.27

3.4

2.7

—

Isolated proteinuria with specified morphological lesion

19.59

30.21

2.6

2.0

—

Heart failure and bmi 25plus

148

344

2.98

30.20

2.4

2.8

—

STROKE

211

596

2.47

30.19

2.4

3.0

—

Other CVD (FINNGEN)

7.09

30.10

2.5

2.9

—

Bacterial pneumonia (organism specified)

172

597

2.64

30.08

2.8

2.5

—

Pain in throat and chest

297

848

2.15

30.05

2.6

3.0

—

Hypo-osmolality and hyponatraemia

188

4.22

30.05

3.1

2.6

—

Parodontitis, under 40 years

6.31

29.94

4.2

2.9

—

Diseases of salivary glands

130

4.95

29.71

3.7

2.0

—

Other diseases of intestine

154

4.59

29.59

3.0

2.7

—

Parodontitis, under 40 years, or operation codes

6.23

29.58

4.2

2.9

—

Hernia of abdominal wall

184

740

2.50

29.42

3.2

2.7

—

Polyneuropathies and other disorders of the peripheral nervous system

104

306

3.43

29.38

3.4

2.5

—

Other necrotizing vasculopathies (FG)

8.08

29.03

2.2

2.6

—

Other retinal disorders

227

795

2.30

28.97

2.9

2.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

186

4.18

28.88

2.9

2.6

—

Thrombocytopenia, unspecified

6.22

28.82

2.9

2.6

—

Other and unspecified polyneuropathies, also in other diseases

267

3.59

28.80

3.5

2.6

—

Acute pancreatitis (for exclusion)

287

3.48

28.63

3.5

2.6

—

Persons with potential health hazards related to communicable diseases

149

544

2.73

28.45

3.4

2.7

—

Crohn's disease of small intestine

6.48

28.17

3.5

3.1

—

Wegener granulomatosis

16.67

28.15

2.5

2.9

—

Candidiasis

169

4.30

28.06

3.8

2.5

—

Abnormalities of breathing

303

870

2.07

27.98

2.6

3.0

—

Other viral hepatitis

6.28

27.91

3.2

—

Excessive attrition of teeth

113

174

3.54

27.71

2.8

2.1

—

Benign neoplasm of other and ill-defined parts of digestive system

159

4.37

27.52

3.6

2.3

—

Parodontitis, under 40 years and operation codes

6.16

27.51

4.2

2.7

—

Parodontitis, operation under 40 years and operation codes

6.16

27.51

4.2

2.7

—

Cholelithiasis, broad definition with cholecystitis

281

923

2.09

27.46

2.9

2.7

—

Non-ischemic cardiomyopathy

116

303

3.16

27.45

2.8

—

Acute nephritic syndrome

13.41

27.24

3.1

3.6

—

Other congenital malformations of the digestive system

8.28

27.20

5.6

2.5

—

Hernia

325

1119

1.98

27.14

3.0

2.8

—

Symptoms and signs involving the circulatory and respiratory systems

344

871

1.98

26.99

2.7

3.0

—

Gastroduodenal ulcer

108

344

3.15

26.73

4.2

2.5

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

5.74

26.72

2.9

1.8

—

Disorders of choroid and retina

287

1026

2.04

26.71

2.9

2.8

—

COPD differential diagnosis

261

595

2.20

26.67

2.5

2.9

—

ILD differential diagnosis

261

595

2.20

26.67

2.5

2.9

—

Chronic gastritis

110

357

3.10

26.50

3.1

2.6

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

169

449

2.58

26.50

2.7

2.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

109

153

3.58

26.39

2.8

2.6

—

Diverticular disease of intestine

247

760

2.17

26.16

2.9

2.8

—

Sequelae with surgical and medical care as external cause

270

3.43

26.15

3.2

2.7

—

Hyperlipidaemia, other/unspecified

138

483

2.72

25.91

2.5

2.7

—

Carcinoma in situ of skin of upper limb, including shoulder

20.54

25.86

2.4

1.8

—

Cholelithiasis

267

903

2.08

25.85

2.8

2.7

—

Symptoms and signs involving the skin and subcutaneous tissue

235

1106

2.12

25.70

2.6

2.8

—

Postprocedural disorders of digestive system, not elsewhere classified

9.34

25.69

3.3

2.3

—

Zoster [herpes zoster]

209

3.76

25.40

3.3

2.5

—

Diaphragmatic hernia

134

497

2.71

25.34

2.7

2.6

—

Hard cardiovascular diseases

281

889

2.03

25.18

2.5

3.0

—

Unspecified haematuria

155

523

2.55

25.13

2.2

2.7

—

Viral hepatitis

5.40

24.95

3.2

3.0

—

Convulsions, not elsewhere classified

255

3.42

24.92

3.0

2.6

—

Fall on same level

382

1162

1.84

24.80

2.8

2.9

—

Syncope and collapse

138

460

2.67

24.70

2.8

2.6

—

Drug-induced osteoporosis with pathological fracture

16.81

24.69

4.8

1.4

—

Unspecified nephritic syndrome

12.98

24.68

2.5

2.8

—

Peripheral arterial reconstruction

218

3.65

24.67

2.0

2.4

—

Other ulcerative colitis

6.30

24.47

4.1

2.9

—

Ventral hernia

312

3.16

24.44

3.1

2.4

—

Cutaneous abscess, furuncle and carbuncle

108

367

2.96

24.08

2.8

—

Open wound of lower leg

181

3.90

24.01

3.2

2.8

—

Dyspnoea

297

1180

1.93

23.99

2.6

2.9

—

Idiopathic gout

103

5.01

23.94

2.6

2.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

142

347

2.69

23.91

2.5

2.3

—

UC patients in KELA-register (code 208), prior to 1994

6.86

23.83

3.6

2.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

146

383

2.62

23.75

2.7

2.3

—

Charcot foot

15.50

23.74

3.4

3.0

—

Asthma, excluding more controls

224

540

2.22

23.74

2.7

2.9

—

Persons encountering health services for examination and investigation

205

444

2.32

23.66

3.0

2.3

—

Mood disorders, excluding more controls

315

1002

1.92

23.66

3.1

2.8

—

Diseases of the eye and adnexa

277

682

2.04

23.46

2.9

2.8

—

Systemic connective tissue disorders

125

466

2.70

23.45

2.8

2.7

—

Malignant neoplasm of other and unspecified parts of mouth

52.18

23.06

4.9

1.8

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

5.66

23.04

3.5

3.1

—

Asthma, unspecified (mode), excluding more controls

154

491

2.47

22.99

2.8

2.9

—

Use of hypnotics and sedatives

358

1136

1.83

22.93

2.9

—

Cellulitis

300

3.12

22.73

2.7

—

Other functional intestinal disorders

142

545

2.49

22.50

2.7

—

Colectomy operation

237

3.40

22.48

2.8

2.6

—

Crohn disease (strict definition, require KELA)

5.77

22.43

3.5

3.3

—

Dental caries 1 and operation codes

266

675

2.03

22.34

2.6

—

Adjustment and management of implanted device

151

4.06

22.21

1.6

2.4

—

Other diseases of pleura

158

593

2.37

22.15

2.5

—

Cardiomyopathy

202

3.59

21.97

1.9

2.7

—

Asthma

230

585

2.11

21.83

2.7

2.9

—

Attention to artificial openings

9.44

21.79

6.0

3.0

—

Venous thromboembolism

184

823

2.18

21.53

2.8

2.7

—

Arthropathies in other diseases classified elsewhere

8.39

21.43

3.1

3.0

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

11.87

21.42

3.4

2.2

—

Anxiety disorders, excluding more controls

270

927

1.94

21.34

3.1

2.8

—

General examination and investigation of persons without complaint and reported diagnosis

189

444

2.27

21.25

3.3

2.3

—

Carcinoma in situ of skin of other and unspecified parts of face

7.03

21.21

2.2

1.7

—

SLE (Finngen)

10.16

21.20

2.2

2.0

—

Chronic hepatitis NAS

15.19

21.17

3.5

3.3

—

Atrial fibrillation and flutter with reimbursement

151

3.49

21.13

2.6

2.7

—

Abnormal findings on examination of blood, without diagnosis

171

720

2.23

21.09

3.2

2.7

—

Presence of cardiac and vascular implants and grafts

126

365

2.62

21.08

1.9

2.1

—

Osteomyelitis

5.55

21.03

3.3

2.5

—

Other complications of surgical and medical care, not elsewhere classified

4.79

21.02

2.9

2.7

—

Diabetic retinopathy, strict definition

295

2.95

20.98

3.3

2.8

—

Need for other prophylactic measures

5.96

20.91

3.6

2.6

—

Dental pulpitis 2

207

490

2.17

20.68

2.8

2.5

—

Other interventions on the root canals of the tooth

9.92

20.66

4.3

2.9

—

Asthma, unspecified (mode)

155

527

2.34

20.64

2.8

2.9

—

Chronic viral hepatitis

5.86

20.58

3.3

3.2

—

Dental caries 1

232

575

2.07

20.57

2.6

2.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

5.56

20.56

3.7

3.2

—

Dental caries 2

252

1029

1.93

20.46

3.2

2.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

214

985

2.02

20.40

2.8

—

Benign neoplasm of mouth and pharynx

110

4.49

20.29

3.3

2.5

—

Dental caries, including avohilmo

231

575

2.06

20.27

2.6

2.5

—

Carcinoma in situ of skin of trunk

13.82

20.26

2.9

2.1

—

Dental operations

191

442

2.22

20.26

2.8

2.2

—

Phlebitis and thrombophlebitis (not including DVT)

274

3.08

20.19

3.0

2.4

—

Depression

313

1196

1.81

20.19

3.2

2.8

—

Substance abuse, excluding more controls

193

810

2.09

20.02

3.0

2.7

—

Endocarditis

9.38

20.02

1.9

2.2

—

In situ neoplasms

119

470

2.54

19.95

2.3

2.6

—

Headache

175

674

2.17

19.91

2.8

2.7

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

226

3.29

19.84

3.3

2.3

—

Vitreous haemorrhage

129

4.15

19.81

3.4

2.7

—

Speech therapy

105

392

2.69

19.74

2.7

2.6

—

Cardiomyopathy, other and unspecified

5.18

19.56

2.1

2.7

—

Other skin changes

209

3.37

19.48

3.0

2.7

—

Finngen Rheumatological endpoints

320

1018

1.80

19.47

2.8

2.9

—

Dental caries 3 and operation codes

271

731

1.91

19.30

2.6

—

Ulcerative colitis (strict definition, require KELA)

241

3.17

19.19

3.6

2.8

—

Disorders of skin appendages

163

754

2.17

19.04

2.7

2.8

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

263

3.06

19.01

3.6

2.7

—

Other viral diseases, not elsewhere classified

232

3.20

18.94

2.9

2.7

—

SLE, ICD10

8.72

18.93

2.2

2.5

—

SLE, strict definition

8.72

18.93

2.2

2.5

—

Melanocytic naevi of lower limb, including hip

8.69

18.92

2.7

2.8

—

Other diseases of pancreas

4.99

18.77

2.9

2.4

—

Gastric ulcer

224

3.23

18.76

4.0

2.5

—

Primary_lymphoid and hematopoietic malignant neoplasms

239

3.15

18.76

2.6

2.3

—

Dental pulpitis 4

337

997

1.76

18.74

2.7

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

148

3.81

18.70

4.4

2.4

—

Dental caries 2 and operation codes

242

1018

1.89

18.67

3.2

2.8

—

Benign neoplasm: Transverse colon

4.67

18.66

3.2

2.5

—

Paroxysmal tachycardia

144

3.65

18.66

2.7

2.6

—

Dental caries 3

244

640

1.95

18.64

2.6

—

Viral pneumonia

144

3.85

18.62

3.0

—

Heart failure and coronary heart disease

119

352

2.53

18.54

2.1

2.6

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

14.50

18.54

1.8

2.3

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

131

371

2.44

18.51

2.6

2.3

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

129

364

2.45

18.49

2.6

2.3

—

Cerebrovascular diseases

242

916

1.90

18.44

2.5

2.8

—

Any mental disorder

353

1023

1.73

18.43

2.8

—

Mood [affective] disorders

327

1240

1.74

18.43

3.2

2.8

—

Acute sinusitis

170

752

2.11

18.40

2.7

3.0

—

Type 1 diabetes, definitions combined

4.59

18.34

2.9

2.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

233

3.15

18.26

3.7

2.8

—

Mood disorders

327

1242

1.73

18.24

3.2

2.8

—

Dental pulpitis 1

335

999

1.75

18.17

2.7

—

Presence of other functional implants

139

423

2.33

18.02

2.9

2.2

—

Diseases of pulp and periapical tissues, including avohilmo

334

998

1.74

17.99

2.7

—

Other diseases of jaws

6.50

17.92

4.6

2.4

—

Osteoporosis with pathological fracture (FG)

5.55

17.90

3.9

2.6

—

Toxic liver disease

13.47

17.74

3.7

2.5

—

Asthma (only as main-diagnosis), excluding more controls

188

540

2.08

17.71

2.5

2.9

—

Asthma (mode)

215

595

1.99

17.64

2.7

2.9

—

Psychiatric diseases

343

999

1.72

17.64

2.8

—

Neurotic, stress-related and somatoform disorders

281

1122

1.78

17.62

3.1

2.8

—

Other benign neoplasms of skin

367

2.63

17.59

2.8

2.3

—

Anxiety disorders

283

1131

1.78

17.51

3.1

2.8

—

COPD (mode)

295

2.67

17.50

2.5

2.8

—

Pain (limb, back, neck, head abdominally)

230

592

1.95

17.46

2.5

2.9

—

Type 2 diabetes, definitions combined

277

917

1.81

17.43

3.0

2.8

—

Type 1 diabetes, strict (exclude DM2)

4.49

17.42

3.0

2.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

6.80

17.41

2.6

—

Diabetic retinopathy

151

427

2.25

17.38

3.1

2.9

—

Vocal cord dysfunction

4.46

17.34

2.5

2.7

—

Osteonecrosis

5.38

17.32

2.6

2.3

—

Umbilical hernia

107

431

2.50

17.30

3.4

2.6

—

Intestinal adhesions without obstruction

4.55

17.27

3.5

2.5

—

Acute upper respiratory infections

316

1150

1.72

17.21

2.4

2.9

—

Noninfectious colitis NAS

162

3.54

17.16

2.8

2.9

—

Carcinoma in situ of skin of upper limb, including shoulder

9.77

17.06

2.4

1.4

—

Elevated blood glucose level

4.69

17.03

3.1

2.4

—

Squamous cell neoplasms and carcinomas of the skin

126

3.92

17.03

2.9

2.3

—

Cardiomyopathies, Primary/intrinsic

135

3.80

17.03

1.8

2.7

—

Paralytic ileus

6.95

17.00

2.1

2.8

—

Systemic lupus erythematosus

7.62

17.00

2.2

2.5

—

Benign neoplasm: Colon, unspecified

355

2.63

16.82

3.1

2.5

—

Benign neoplasm: Ascending colon

123

3.93

16.77

2.9

2.3

—

Cardiomyopathy (excluding other)

146

3.66

16.72

1.8

2.7

—

Total colectomy operation

5.86

16.68

3.1

3.0

—

Total colectomy

5.86

16.68

3.1

3.0

—

Other diseases of blood and blood-forming organs, wide

318

2.72

16.56

3.1

2.7

—

Benign neoplasm: Sigmoid colon

166

3.45

16.54

2.8

2.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

129

574

2.24

16.39

3.0

2.5

—

Type 2 diabetes, strict (exclude DM1)

277

937

1.77

16.30

3.0

2.8

—

Other (not insulin) diabetes medications

282

970

1.76

16.25

3.0

2.8

—

Intestinal malabsorption

5.88

16.20

3.5

2.3

—

Benign neoplasm: Skin of trunk

7.95

16.18

2.9

2.5

—

Amputation of foot

7.60

16.17

3.5

2.5

—

Diseases of the respiratory system

193

483

2.01

15.89

2.5

2.9

—

Benign neoplasm: Tongue

10.17

15.84

3.0

2.3

—

Type 2 diabetes, definitions combined, including avohilmo

276

934

1.75

15.75

3.0

2.8

—

Acute posthaemorrhagic anaemia

7.30

15.70

3.5

2.2

—

Other metabolic disorders

120

3.86

15.69

2.3

2.8

—

Parasetamol

257

729

1.80

15.55

2.5

3.1

—

Abnormal findings on diagnostic imaging of lung

151

716

2.06

15.49

2.8

2.6

—

Asthma (only as main-diagnosis)

190

585

1.96

15.49

2.5

2.9

—

Dental pulpitis 2, only avohilmo

202

533

1.94

15.35

2.7

2.5

—

Hypoplasia of dental enamel , including avohilmo

10.65

15.35

3.1

2.6

—

Other disorders of glucose regulation and pancreatic internal secretion

100

4.14

15.34

3.4

2.6

—

Dermatitis

190

1007

1.89

15.34

2.8

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.66

15.30

2.7

2.2

—

Dermatitis and eczema

328

1308

1.65

15.28

2.9

2.8

—

Mental and behavioural disorders due to psychoactive substance use

200

1016

1.86

15.25

3.0

2.8

—

Asthma-related infections

181

930

1.92

15.24

2.7

—

Asthma, hospital admission 2, infections

181

930

1.92

15.24

2.7

—

Dysphagia

270

2.79

15.22

3.5

2.5

—

Molar incisor enamel hypoplasia

10.55

15.21

3.1

2.6

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

114

3.89

15.18

4.0

2.7

—

Cardiac arrest

6.78

15.14

2.5

2.8

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

195

2.98

15.12

3.2

2.2

—

Asthma-related pneumonia

114

502

2.28

15.11

2.9

2.6

—

Asthma-related pneumonia or sepsis

114

502

2.28

15.10

2.9

2.6

—

Asthma, hospital admissions 3, pneumonia

114

502

2.28

15.10

2.9

2.6

—

Benign neoplasm of other and ill-defined parts of digestive system

239

2.91

15.06

3.6

2.6

—

Disorder of lipoprotein metabolism, unspecified

157

3.40

15.02

2.0

2.7

—

Melanocytic naevi, other sites/unspecified

5.04

14.77

3.4

3.0

—

Personal history of other diseases and conditions

5.17

14.74

3.8

1.3

—

Molar incisor enamel hypoplasia, with caries

+∞

14.70

3.3

0.0

—

Benign neoplasm: Descending colon

5.33

14.66

2.6

2.5

—

Stroke, excluding SAH

188

737

1.90

14.62

2.5

2.7

—

Coronary atherosclerosis

222

791

1.81

14.52

2.5

3.0

—

Other diseases of stomach and duodenum

4.97

14.52

4.5

2.3

—

Hypoparathyroidism

7.80

14.45

3.1

1.9

—

Other and unspecified dermatitis

158

804

1.97

14.44

2.7

—

Falls/tendency to fall

334

1023

1.64

14.39

2.9

2.8

—

Other and unspecified acquired haemolytic anaemias

13.27

14.34

3.7

1.9

—

Encephalopathy

13.23

14.34

4.0

2.2

—

Substance abuse

193

1003

1.84

14.32

3.0

2.7

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

172

3.22

14.32

2.6

—

Other nutritional deficiencies

196

1049

1.83

14.27

3.1

2.8

—

Viral and other specified intestinal infections

224

2.89

14.24

3.1

2.4

—

Valvular heart disease excluding rheumatic fever

139

485

2.10

14.23

2.5

2.9

—

Acne

4.04

14.21

2.7

2.8

—

Varicella [chickenpox]

5.35

14.20

3.0

2.9

—

Fibrosis of liver

32.44

14.11

4.2

2.3

—

Anxiety (asthma-related co-morbidities)

174

717

1.92

14.10

2.9

2.8

—

Amputation of ankle bones

8.09

14.07

3.1

2.2

—

Vascular diseases of the intestine

6.75

14.04

4.1

2.7

—

Haemorrhage, not elsewhere classified

7.50

14.00

2.8

2.7

—

Chronic ulcer of skin, not elsewhere classified

4.57

14.00

2.6

2.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

292

1242

1.65

13.96

2.6

2.9

—

Embedded teeth, including avohilmo

4.14

13.91

3.5

2.6

—

DVT of lower extremities

223

2.88

13.84

3.2

2.5

—

COPD-related respiratory insufficiency

156

3.29

13.78

2.9

2.5

—

Vascular disorders of the intestines

4.74

13.76

4.4

2.3

—

Pure hypercholesterolaemia

207

768

1.81

13.65

2.6

3.0

—

137

671

2.03

13.64

2.5

2.8

—

Lung transplant status

12.30

13.64

2.1

2.8

—

Lung transplantation

12.30

13.64

2.1

2.8

—

Protozoal diseases

6.90

13.62

3.3

2.7

—

Gastro-oesophageal reflux disease

191

932

1.82

13.45

2.5

2.7

—

Actinic keratosis

111

483

2.19

13.34

2.6

2.5

—

Malignant neoplasm of floor of mouth

31.30

13.25

6.4

2.0

—

All influenza (not pneumonia)

191

3.00

13.23

3.4

3.0

—

Pericarditis

6.98

13.16

3.1

2.7

—

Non-rheumatic valve diseases

136

485

2.05

13.15

2.5

2.9

—

Low back pain

227

1013

1.73

13.15

2.9

—

Persons encountering health services in other circumstances

105

475

2.22

13.13

3.2

2.5

—

Acne vulgaris

4.41

13.07

2.7

3.1

—

Pain in joint

167

579

1.91

13.02

2.7

2.9

—

Skin changes due to chronic exposure to nonionizing radiation

113

499

2.15

12.98

2.6

2.5

—

Obesity and other hyperalimentation

186

1024

1.80

12.95

3.0

2.8

—

Pneumocystosis

9.14

12.95

4.0

1.8

—

Obesity

185

1019

1.80

12.89

3.0

2.8

—

Carcinoma in situ of skin of other and unspecified parts of face

4.36

12.86

2.2

—

Cough

117

534

2.11

12.83

2.7

2.9

—

Abnormalities of gait and mobility

148

3.27

12.83

2.5

2.6

—

Disorders of vitreous body and globe

150

762

1.93

12.82

3.0

2.7

—

Systemic lupus erythematosus, unspecified

7.14

12.73

2.3

2.6

—

Ischemic heart diseases

244

902

1.70

12.73

2.5

3.1

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

110

3.66

12.72

2.5

2.3

—

119

538

2.09

12.67

2.6

2.5

—

Mental and behavioural disorders due to alcohol

171

908

1.84

12.67

2.9

2.7

—

DVT of lower extremities and pulmonary embolism

126

619

2.04

12.67

2.7

2.6

—

Melanocytic naevi of lower limb, including hip

5.52

12.60

2.7

2.8

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

25.45

12.58

2.8

3.9

—

Ischaemic heart disease, wide definition

240

886

1.70

12.56

2.5

3.0

—

Acquired absence of organs, not elsewhere classified

25.19

12.55

2.2

1.3

—

Stroke, including SAH

192

794

1.79

12.54

2.5

2.7

—

Diabetic neuropathy

218

2.81

12.52

3.5

2.9

—

Hypothyroidism, strict autoimmune

174

620

1.86

12.51

2.9

2.5

—

Acidosis

20.49

12.51

2.1

2.4

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

171

3.06

12.49

2.5

2.4

—

Disorders of vitreous body

146

745

1.92

12.47

3.0

2.7

—

Biliary cirrhosis, secondary

+∞

12.45

3.6

0.0

—

Other CVD

237

2.71

12.40

2.5

2.6

—

Pneumonia due to other infectious organisms, not elsewhere classified

6.54

12.39

3.2

3.0

—

All anxiety disorders

174

768

1.83

12.29

2.9

2.8

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

152

808

1.88

12.26

2.9

2.7

—

Pruritus

128

3.38

12.16

3.3

2.6

—

Retinal detachments and breaks

110

524

2.11

12.15

3.0

2.6

—

Other diseases of pericardium

6.06

12.14

2.4

—

Benign neoplasm of mouth and pharynx

159

3.11

12.07

3.3

2.8

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

8.99

12.04

3.5

2.3

—

Benign neoplasm: Duodenum

8.96

12.03

3.7

2.4

—

Later onset COPD, excluding more controls

165

2.85

12.01

2.0

2.5

—

Pleural effusion

208

2.81

11.97

2.7

2.5

—

Use of pramipexole

306

2.46

11.96

2.9

2.6

—

Delirium, not induced by alcohol and other psychoactive substances

115

3.50

11.91

2.5

2.3

—

Depression or dysthymia

224

732

1.72

11.89

3.1

2.8

—

All dysplastic lesions of the vulva

5.90

11.81

2.8

2.5

—

Drug-induced osteoporosis

12.34

11.79

3.1

2.0

—

Disorders of oesophagus in diseases classified elsewhere

9.50

11.69

4.8

1.8

—

Other disorders of lacrimal gland

102

480

2.13

11.65

2.6

2.7

—

Benign neoplasm: Caecum

3.85

11.62

2.3

2.5

—

Carcinoma in situ of skin of trunk

6.44

11.58

2.9

2.2

—

Immunodeficiencies

5.05

11.48

2.5

3.0

—

Codeine or tramadol medication

336

1214

1.54

11.45

2.5

2.9

—

Cerebral cysts

4.42

11.45

3.4

2.8

—

Obesity, other/unspecified

103

491

2.10

11.38

3.1

2.7

—

Retention of urine

388

2.16

11.38

2.5

2.7

—

Conduction disorders

281

2.37

11.38

2.0

2.8

—

Embedded and impacted teeth

242

2.50

11.36

3.5

2.5

—

Nonalcoholic fatty liver disease

129

3.28

11.34

5.0

2.7

—

Other coagulation defects

4.14

11.32

1.9

2.9

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

261

2.54

11.26

2.8

2.6

—

Right hemicolectomy

4.47

11.20

2.2

2.6

—

Benign neoplasm: Tongue

6.53

11.12

3.0

2.2

—

Benign neoplasm: Small intestine

6.50

11.10

3.4

2.0

—

Acute suppurative otitis media

294

2.39

11.10

2.6

2.8

—

Benign neoplasm: Transverse colon

136

3.19

11.08

3.2

2.5

—

Duodenal ulcer

126

3.27

11.06

4.3

2.4

—

Heart failure and hypertrophic cardiomyopathy

8.08

11.05

1.5

1.7

—

All dysplastic lesions of the vagina

7.38

11.01

3.7

2.7

—

Other obstructive and reflux uropathy

7.33

10.99

2.2

2.7

—

Other and unspecified coagulation defects

4.85

10.96

1.8

2.8

—

Sequelae of other external causes

4.53

10.96

3.3

2.6

—

Other respiratory disorders and diseases

271

2.48

10.92

2.2

2.5

—

Other diseases of the respiratory system

271

2.48

10.92

2.2

2.5

—

Type 1 diabetes, strict definition, subgroup 1

4.50

10.90

3.0

2.1

—

Hypotension

192

2.77

10.76

2.6

—

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

22.20

10.76

3.9

2.1

—

Carcinoma in situ of skin

4.58

10.71

2.3

1.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

427

2.14

10.50

2.4

2.8

—

Decubitus ulcer and pressure area

4.50

10.49

2.4

2.3

—

Unspecified acute lower respiratory infection

201

2.70

10.43

2.6

2.8

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

101

3.49

10.42

2.7

2.4

—

Neurological diseases, wide definition

151

2.50

10.41

2.5

—

Rash and other nonspecific skin eruption

111

3.35

10.39

2.8

2.7

—

Abrasion of teeth

155

2.71

10.35

3.4

2.2

—

Benzodiazepine use

285

1322

1.54

10.30

2.7

2.9

—

Melanocytic naevi, other sites/unspecified

3.76

10.30

3.4

2.6

—

Abscess of anal and rectal regions

102

3.45

10.28

2.3

3.2

—

Covid-19 suspected case

261

2.46

10.27

3.4

2.6

—

LSIL lesion of the vagina

8.86

10.27

3.8

2.9

—

Recurring oral aphthae

4.74

10.25

3.2

2.4

—

Tooth eruption problems

141

3.03

10.24

3.5

2.6

—

Pulmonary oedema

7.92

10.17

3.2

1.7

—

External causes of morbidity and mortality

186

537

1.74

10.15

2.8

2.7

—

Disorders of thyroid, IBD co-morbidities

111

3.03

10.13

2.8

2.7

—

Suppurative and unspecified otitis media

428

2.06

10.13

2.8

—

Other specified and unspecified disorders of eye and adnexa

5.32

10.12

2.6

2.8

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

108

3.35

10.11

2.0

2.7

—

Other disorders of adrenal gland

5.05

10.05

3.9

2.2

—

Temporomandibular joint disorders

155

2.91

10.04

3.1

2.8

—

Personality disorders, excluding more controls

313

2.31

10.03

2.7

2.8

—

Misadventures to patients during surgical and medical care

166

2.85

10.03

2.9

2.8

—

Malignant neoplasm of skin

166

719

1.74

9.97

2.7

—

Hypersensitivity angiitis

21.54

9.97

3.6

2.0

—

Special screening examination for infectious and parasitic diseases

201

2.46

9.97

2.1

2.3

—

Oral lichen ruber planus

6.18

9.95

4.7

2.3

—

Other autoimmune haemolytic anaemias

9.48

9.92

2.2

2.0

—

Fracture of femur

314

2.25

9.91

2.5

2.6

—

Type 1 diabetes, strict definition

4.04

9.91

3.0

2.3

—

Carcinoma in situ of skin of scalp and neck

16.98

9.90

2.2

1.8

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

9.36

9.89

3.2

2.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

162

2.86

9.88

3.4

2.5

—

Fracture of lumbar spine and pelvis

278

2.38

9.86

2.9

2.5

—

Benign neoplasm: Stomach

3.73

9.86

4.1

2.6

—

Injuries to the knee and lower leg

333

1286

1.48

9.85

2.8

—

Obesity due to excess calories

132

723

1.83

9.83

2.8

2.7

—

Vitamin B12 deficiency anaemia

110

3.29

9.83

2.3

—

Benign neoplasm: Other and unspecified parts of mouth

6.47

9.82

2.0

2.4

—

Ischaemic Stroke, excluding all haemorrhages

160

693

1.75

9.77

2.5

2.7

—

Diseases of spleen

8.28

9.77

3.9

3.1

—

Benign neoplasm: Rectum, anus and anal canal

191

2.68

9.76

3.1

2.3

—

Enteropathic arthropathies

6.92

9.75

3.2

3.5

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

7.49

9.72

2.3

2.6

—

Hypoglycaemia, other or unspecified

3.69

9.70

3.3

2.8

—

Cholecystectomy

193

1039

1.65

9.68

2.5

2.8

—

Dorsalgia

290

1032

1.52

9.62

2.7

2.9

—

Abnormalities of heart beat

459

2.03

9.58

2.5

2.8

—

Other diseases of anus and rectum

364

2.17

9.58

2.6

—

Other anxiety disorders

120

567

1.88

9.56

2.7

2.8

—

Basal cell carcinoma

147

661

1.78

9.56

2.6

—

Hypertrophic cardiomyopathy

4.64

9.55

1.6

2.5

—

Nonorganic sleeping disorders, excluding more controls

199

2.62

9.54

2.4

2.7

—

Benign neoplasm: Rectum

171

2.76

9.51

3.1

2.4

—

Benign neoplasm: Ascending colon

177

2.73

9.48

2.9

2.6

—

KRA_PSY_EATING, excluding more controls

4.59

9.48

2.2

2.5

—

Alcohol use disorder, ICD-based

135

754

1.80

9.46

2.9

2.8

—

Other noninflammatory disorders of vulva and perineum

3.59

9.37

3.5

2.9

—

Other renal tubulo-interstitial diseases

8.67

9.36

3.3

3.0

—

Alcohol-induced chronic pancreatitis

104

3.30

9.30

2.9

3.0

—

Viral pneumonia (unknown virus, not influenza)

3.65

9.26

3.2

2.6

—

Basal cell carcinoma, including avohilmo

149

671

1.75

9.26

2.6

—

Lower back pain or/and sciatica

287

1331

1.50

9.24

2.9

2.8

—

Collagenous colitis

100

3.32

9.16

3.2

2.6

—

Early onset COPD, excluding more controls

251

2.40

9.15

2.8

—

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

16.26

9.12

4.1

2.4

—

Benign neoplasm: Skin of trunk

4.45

9.09

2.9

2.5

—

Other arrhythmias

162

730

1.70

9.05

2.4

3.0

—

Autoimmune hepatitis

24.98

8.98

4.8

1.2

—

Major coronary heart disease event

209

874

1.60

8.93

2.5

2.9

—

Other symptoms and signs involving the digestive system and abdomen

149

2.83

8.93

2.7

2.4

—

Disorders of lacrimal system

114

616

1.86

8.92

2.6

2.8

—

Other surgical follow-up care

7.29

8.85

3.1

3.5

—

Alcohol-induced acute pancreatitis

4.52

8.85

3.3

2.8

—

TMD related operations

237

2.42

8.84

3.9

2.7

—

Other external causes of accidental injury

230

730

1.58

8.84

2.8

—

Neovascular glaucoma

4.70

8.83

2.6

3.0

—

COPD

129

594

1.80

8.79

2.4

2.6

—

Abnormal involuntary movements

179

2.64

8.75

2.0

2.8

—

Small fibre neuropathy

5.39

8.71

4.1

2.4

—

Retinal vascular disorders

146

2.82

8.67

3.1

2.3

—

Myocardial infarction

153

643

1.71

8.65

2.4

2.9

—

Benign neoplasm: Descending colon

3.48

8.64

2.6

2.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

354

2.13

8.63

2.6

—

Diseases of the myoneural junction and muscle

152

2.78

8.63

3.8

2.7

—

Suppurative and necrotic conditions of lower respiratory tract

3.75

8.62

3.3

2.7

—

Hepatomegaly and splenomegaly, not elsewhere classified

16.80

8.61

3.8

1.4

—

Intracerebral haemorrhage

136

2.88

8.56

2.6

2.5

—

ILD, hospital admissions 3, with pneumonia sepsis

3.62

8.55

3.2

2.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

140

639

1.73

8.43

2.7

2.6

—

Injuries to the head

299

1336

1.46

8.42

2.8

—

Intracranial trauma

158

705

1.68

8.37

3.0

2.9

—

COPD, hospital admission 2, with asthma infections

406

1.96

8.37

2.1

2.5

—

Carcinoma in situ of skin of scalp and neck

5.87

8.35

2.2

2.0

—

Campylobacter enteritis

5.84

8.34

2.9

3.3

—

ILD, hospital admission 2, with pulmonary infections

3.32

8.33

3.1

3.0

—

Arterial embolism and thrombosis

3.99

8.32

2.0

2.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

154

927

1.66

8.30

2.5

2.8

—

Other respiratory diseases principally affecting the interstitium

232

2.38

8.29

2.8

2.5

—

Calcific aortic valvular stenosis, including rheumatic fever

385

2.04

8.23

2.4

2.5

—

Microscopic polyangiitis

18.17

8.19

2.1

2.0

—

Glaucoma secondary to other eye disorders

4.39

8.16

2.6

2.9

—

Other symptoms and signs involving the urinary system

129

2.88

8.15

3.4

2.7

—

Adrenocortical insufficiency

5.05

8.15

4.5

2.1

—

Other arthritis (FG)

437

1.97

8.13

2.3

2.7

—

Sulfonylureas

410

1.91

8.13

2.4

2.6

—

Other specific joint derangements/joint disorders

205

879

1.57

8.11

2.8

2.9

—

Accidents

226

730

1.55

8.11

2.8

—

Disorders of eyelid, lacrimal system and orbit

226

1166

1.52

8.10

2.6

2.8

—

Calculus of lower urinary tract

3.78

8.07

1.8

2.9

—

Benign neoplasm: Duodenum

5.64

8.04

3.7

1.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

439

1.96

8.03

2.5

2.6

—

Other specified and unspecified personality disorders

114

3.00

8.03

2.0

2.9

—

Oral leukoplakia

7.18

8.02

5.9

1.9

—

Discitis, unspecified

7.99

8.01

1.9

3.2

—

Type1 diabetes, definitions combined, early onset

3.76

8.01

3.3

3.2

—

Other and unspecified local infections of skin and subcutaneous tissue

109

3.05

7.99

3.3

2.7

—

Disorders of sclera, cornea, iris and ciliary body

153

930

1.65

7.98

2.9

2.7

—

AV-block

153

2.62

7.96

1.9

2.6

—

Oral leukoplakia, including avohilmo

5.23

7.95

5.0

2.7

—

Other chronic obstructive pulmonary disease

121

570

1.77

7.92

2.4

2.6

—

Special screening examination for neoplasms

4.89

7.89

5.5

2.8

—

Any operation in hilmo

+∞

7.86

2.1

0.0

—

Calcific aortic valvular stenosis, operated

386

2.01

7.84

2.4

2.5

—

Calcific aortic valvular stenosis

386

2.01

7.84

2.4

2.5

—

Operations 2 for CAVS

386

2.01

7.84

2.4

2.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

386

2.01

7.84

2.4

2.5

—

Other disorders of eye and adnexa

178

2.54

7.80

2.8

2.5

—

Other specified/unspecified systemic involvement of connective tissue

4.07

7.80

2.5

2.4

—

LSIL lesion of the vulva

5.42

7.74

2.7

2.6

—

Benign neoplasm: Rectosigmoid junction

5.40

7.73

3.7

2.4

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

5.40

7.73

2.3

2.6

—

Melanocytic naevi of other and unspecified parts of face

4.35

7.68

2.0

3.2

—

Explicit fungal Sepsis

19.20

7.68

4.2

2.2

—

Mental disorders, not otherwise specified

3.20

7.65

2.9

2.8

—

Retinal vascular occlusion

145

2.70

7.65

3.3

2.3

—

Benign neoplasm: Pancreas

6.75

7.62

2.2

2.7

—

Crohn disease (strict definition, all UC cases excluded)

3.99

7.62

3.5

2.8

—

Benign neoplasm: Sigmoid colon

254

2.25

7.61

2.8

2.6

—

Abnormal results of function studies

107

3.01

7.61

2.8

2.7

—

Amyloidosis

8.44

7.59

1.5

1.9

—

Conjunctivitis (acute, non atopic)

385

2.00

7.58

2.7

2.6

—

Soft tissue disorders

282

1007

1.46

7.58

2.9

—

Volvulus

5.67

7.56

5.1

2.9

—

Major coronary heart disease event excluding revascularizations

188

829

1.57

7.56

2.2

2.9

—

Fibrosis and sclerosis of liver

+∞

7.55

6.4

0.0

—

Other antidepressants

295

1069

1.44

7.53

2.7

2.9

—

Polyuria

294

2.15

7.52

3.2

2.6

—

Generalized anxiety disorder

158

2.60

7.50

3.3

2.6

—

Other arterial embolism and thrombosis

5.23

7.46

2.3

2.8

—

Chronic lower respiratory diseases

329

1265

1.41

7.45

2.6

2.9

—

Infection of intervertebral disc (pyogenic)

13.67

7.42

3.7

3.6

—

Other local infections of skin and subcutaneous tissue

125

2.82

7.41

3.3

2.7

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

3.44

7.39

1.6

2.2

—

Other benign neoplasms of skin

539

1.82

7.34

2.8

2.5

—

Dizziness and giddiness

197

1047

1.53

7.31

2.5

2.9

—

Coronary revascularization (ANGIO or CABG)

133

550

1.69

7.23

2.4

2.9

—

Myocardial infarction, without ST-elevation

107

558

1.77

7.23

2.1

2.5

—

Other specified and unspecified retinal disorders

4.52

7.19

3.9

3.0

—

Diffuse large B-cell lymphoma, helper endpoint

4.74

7.17

2.5

2.6

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

4.74

7.17

2.5

2.6

—

Cardiomyopathy, Hypertrophic obstructive

6.97

7.17

1.7

2.4

—

Infections with a predominantly sexual mode of transmission

422

1.92

7.16

3.3

2.6

—

Mixed and other personality disorders

3.07

7.15

2.4

3.0

—

Other pleural conditions

122

2.80

7.15

2.8

2.5

—

Disturbances of skin sensation

361

2.00

7.13

2.3

2.8

—

Injury, poisoning and certain other consequences of external causes

141

419

1.69

7.12

2.9

2.6

—

Injuries to the hip and thigh

122

660

1.69

7.04

2.8

2.6

—

Other symptoms and signs involving cognitive functions and awareness

114

621

1.73

7.04

2.6

2.7

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

108

482

1.76

6.99

2.7

2.8

—

Other disorders of white blood cells

3.51

6.99

2.5

—

Other disorders of veins

548

1.79

6.95

2.5

2.7

—

All dysplastic lesions of the cervix uteri, vagina or vulva

315

2.06

6.94

3.2

2.7

—

COPD related to multimorbidity

104

495

1.77

6.94

2.2

2.5

—

Cramp and spasm

3.72

6.92

1.7

2.6

—

COPD, early/later onset

121

604

1.69

6.89

2.4

2.6

—

Other specified/unspecified arthritis

401

1.93

6.86

2.2

2.8

—

Open wound of forearm

114

2.82

6.83

3.9

2.8

—

Benign neoplasm: Small intestine

4.13

6.82

3.4

2.3

—

Pulmonary heart disease, diseases of pulmonary circulation

451

1.87

6.82

2.2

2.5

—

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

6.53

6.78

1.0

2.1

—

Other and unspecified vascular occlusions

104

2.90

6.73

3.6

2.3

—

Other and unspecified diseases of blood and blood-forming organs

5.06

6.72

4.0

2.8

—

conjunctival haemorrhage

3.15

6.71

3.5

2.4

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

198

2.33

6.70

3.1

3.0

—

Idiopathic thrombocytopenic purpura

4.74

6.70

3.5

2.9

—

Other specified disorders of kidney and ureter

4.73

6.70

3.8

2.3

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

4.72

6.69

2.5

2.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

3.40

6.69

3.7

2.5

—

Benign neoplasm of middle ear and respiratory system

3.31

6.68

2.7

2.4

—

Injuries to the thorax

124

750

1.66

6.67

3.0

2.7

—

Nonorganic sleeping disorders

237

2.20

6.63

2.4

2.7

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

260

2.13

6.63

1.9

2.2

—

Diseases of tongue

4.02

6.62

4.5

2.4

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

2.96

6.53

3.4

2.6

—

Asthma (diagnoses ohter than nonallergic)

224

1322

1.45

6.53

2.7

2.8

—

Hydrocele

164

2.45

6.50

2.4

2.8

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

164

2.45

6.49

2.6

2.3

—

Symptoms and signs involving speech and voice

452

1.84

6.47

2.7

2.6

—

Alcohol dependence

475

1.82

6.42

3.3

2.8

—

Eating disorders

2.92

6.40

2.4

2.6

—

Abnormal serum enzyme levels

491

1.79

6.37

3.3

2.6

—

Spondylopathies

217

899

1.47

6.36

2.4

3.0

—

Exposure to other specified factors

194

1231

1.48

6.35

2.6

2.9

—

Cardiodefibrillation

571

1.74

6.34

2.4

2.6

—

Myocardial infarction, strict

134

604

1.62

6.34

2.3

3.0

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

6.77

6.33

3.0

2.3

—

Drug-induced hypoglycaemia without coma

6.76

6.33

3.3

2.5

—

Carcinoma in situ of skin of lower limb, including hip

6.76

6.33

1.7

1.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

6.76

6.33

1.8

3.1

—

Benign neoplasm: Skin of scalp and neck

6.73

6.32

2.0

3.4

—

Thrombotic microangiopathy

18.70

6.32

3.2

2.2

—

Polycythaemia vera

5.50

6.29

2.0

2.7

—

Carcinoma in situ of skin of ear and external auricular canal

18.32

6.28

1.7

2.4

—

Pain associated with micturition

137

2.57

6.27

3.3

2.7

—

Other or ill-defined heart diseases

3.85

6.25

2.4

3.0

—

Presence of other devices

192

2.30

6.23

4.1

2.0

—

Recurring oral aphthae, including avohilmo

174

2.37

6.20

3.0

2.7

—

Dermatophytosis

168

2.39

6.19

2.5

2.7

—

Non-allergic asthma (mode), excluding more controls

185

2.31

6.15

2.4

2.8

—

Diseases of the musculoskeletal system and connective tissue

146

457

1.60

6.15

2.9

2.8

—

Other noninflammatory disorders of vagina

3.21

6.14

3.6

2.5

—

Special screening examination for other diseases and disorders

3.21

6.13

3.0

2.2

—

Abscess of lung

5.89

6.13

3.6

2.4

—

Amyloidosis, other/unspecified

12.69

6.10

1.5

2.4

—

Ovarian cyst

283

1.82

6.08

2.7

3.0

—

Injuries to the ankle and foot

179

1096

1.49

6.06

2.9

—

COPD, hospital admissions

117

603

1.65

6.03

2.4

2.6

—

Juvenile arthritis (FINNGEN)

4.31

6.02

3.1

2.9

—

Benign neoplasm: Caecum

134

2.55

6.02

2.3

2.4

—

Other neurological diseases

186

1012

1.48

5.99

2.7

2.8

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

3.88

5.98

1.3

2.3

—

Obesity related asthma

523

1.74

5.97

2.8

2.7

—

Melanocytic naevi of scalp and neck

6.31

5.96

3.3

3.2

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

15.51

5.95

1.6

2.2

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

129

2.57

5.94

2.4

2.3

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

172

2.24

5.93

3.3

2.1

—

Cholecystitis

153

2.43

5.93

3.5

2.6

—

Irregular menses

104

500

1.69

5.91

3.0

2.8

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

459

1.79

5.89

2.8

2.7

—

Injuries to unspecified part of trunk, limb or body region

118

2.64

5.88

2.9

2.7

—

Lung cancer and mesothelioma

183

2.20

5.87

3.3

2.6

—

Myalgia

304

1.98

5.85

2.5

2.6

—

LSIL lesion of the cervix uteri, vagina or vulva

148

2.44

5.84

3.4

2.5

—

Superficial injury of lower leg

318

1.95

5.84

2.7

2.6

—

Diseases of middle ear and mastoid

143

755

1.55

5.81

2.7

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

5.54

5.81

1.1

2.3

—

Carcinoma in situ of skin of lower limb, including hip

11.27

5.81

1.7

2.0

—

Epilepsy

467

1.78

5.81

2.9

2.7

—

Fracture of rib(s), sternum and thoracic spine

476

1.77

5.80

2.7

—

Coronary artery bypass grafting

314

1.85

5.76

2.0

2.8

—

Cysts of oral region, not elsewhere classified

4.67

5.74

2.2

2.3

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

3.47

5.73

2.2

2.7

—

Hypermetropia

3.35

5.71

2.5

2.7

—

Other and unspecified myopathies

109

2.68

5.66

3.7

2.4

—

Malignant neoplasm of oropharynx

5.98

5.64

4.3

2.6

—

Alcoholic gastritis

5.97

5.64

3.7

2.3

—

Malignant neoplasm of base of tongue

13.42

5.64

4.7

2.0

—

Benign neoplasm: Skin of lower limb, including hip

5.93

5.63

2.7

3.4

—

Bacterial, viral and other infectious agents

127

2.53

5.61

2.4

2.8

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

13.14

5.61

3.2

2.7

—

Psoriatic and enteropathic arthropathies

145

2.42

5.61

3.5

3.0

—

Other symptoms and signs involving the circulatory and respiratory systems

3.41

5.58

2.9

2.8

—

Visual disturbances and blindness

125

795

1.58

5.57

2.7

—

Complications of other internal prosthetic devices, implants and grafts

4.27

5.56

2.6

2.9

—

Other systemic involvement of connective tissue (FG)

308

1.94

5.54

2.9

2.6

—

Vitamin deficiency

3.83

5.54

3.3

2.5

—

Vitamin deficiency, wide

3.83

5.54

3.3

2.5

—

Pulmonary embolism

417

1.80

5.53

2.2

2.5

—

Agranulocytosis

146

2.41

5.53

3.6

2.5

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

4.51

5.51

3.7

3.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

328

1.85

5.50

2.2

2.4

—

Pulmonary heart disease

418

1.80

5.49

2.2

2.5

—

Disorders of plasma-protein metabolism, not elsewhere classified

16.46

5.44

3.1

3.4

—

Otitis media, unspecified

2.74

5.44

3.1

2.8

—

Neuromuscular dysfunction of bladder

100

2.71

5.42

2.9

2.7

—

Preparation and fitting of bite rail to mouth

198

2.18

5.42

3.1

2.6

—

Other systemic involvement of connective tissue

334

1.89

5.41

2.9

2.6

—

Personality disorders

399

1.81

5.38

2.7

2.8

—

Benign neoplasm: Other and unspecified parts of mouth

3.76

5.37

2.0

2.6

—

Substance use, excluding alcohol

286

1.96

5.37

2.8

2.7

—

Other and unspecified disorders of white blood cells

3.75

5.37

2.5

2.7

—

Faecal incontinence

3.03

5.37

1.7

2.1

—

Other salmonella infections

4.15

5.36

3.7

3.0

—

Traumatic subdural haemorrhage

158

2.31

5.34

2.7

2.4

—

Other bacterial agents as the cause of diseases classified to other chapters

11.50

5.32

2.0

—

Carcinoma in situ of skin

2.79

5.30

2.3

2.4

—

Non-allergic asthma (mode)

198

2.16

5.29

2.4

2.9

—

Iridocyclitis

330

1.88

5.27

2.9

2.6

—

Spondyloarthritis

220

2.10

5.27

2.4

2.7

—

Background retinopathy and retinal vascular changes

5.06

5.27

3.2

2.0

—

Immunodeficiency with predominantly antibody defects

4.66

5.27

2.4

2.7

—

Unspecified fall

121

769

1.56

5.25

2.8

2.6

—

Recurrent or chronic depression

105

464

1.64

5.24

3.4

3.0

—

Eating disorder

2.98

5.24

2.2

2.5

—

Symptoms and signs concerning food and fluid intake

2.83

5.22

3.1

2.8

—

Reactive arthropathies

108

2.60

5.21

2.8

3.1

—

Other and unspecified drugs and medicaments

2.76

5.20

3.0

2.5

—

Oral lichen ruber planus, including avohilmo

2.90

5.19

4.1

2.6

—

Anterior Iridocyclitis

290

1.94

5.18

3.0

2.7

—

Other aneurysm

3.24

5.17

2.6

2.8

—

Other juvenile arthritis

4.02

5.17

2.9

3.2

—

Melanocytic naevi of other and unspecified parts of face

3.24

5.17

2.0

3.0

—

Fracture of lower leg, including ankle

141

934

1.51

5.16

2.9

—

Follow-up examination after treatment for malignant neoplasms

2.69

5.16

3.0

2.3

—

Nerve, nerve root and plexus disorders

274

1276

1.35

5.13

2.4

2.9

—

Disorders of adult personality and behaviour

428

1.76

5.11

2.6

2.7

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

177

2.21

5.10

1.8

2.2

—

Nonischemic cardiomyopathy

3.02

5.10

2.3

3.1

—

Benign neoplasm: Parotid gland

3.01

5.10

3.5

2.6

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

4.23

5.09

1.7

2.5

—

Sleep disorders

285

1.93

5.08

2.4

2.7

—

Dysplasia of cervi uteri

217

1.96

5.07

3.4

3.1

—

Drug-induced adrenocortical insufficiency

5.34

5.05

5.9

2.3

—

Other and unspecified aplastic anaemias

10.20

5.05

1.9

1.8

—

Other dorsopathies, not elsewhere classified

266

1033

1.36

5.05

2.8

2.9

—

Other disorders of iris and ciliary body

4.49

5.04

2.5

2.8

—

Other chronic obstructive pulmonary disease, including avohilmo

134

734

1.52

5.02

2.4

2.7

—

Syphilis

4.83

5.02

3.5

3.0

—

Open wound of head

135

883

1.51

4.99

2.7

—

Exclusions for E4_PCOS_BROAD

225

2.05

4.99

3.2

2.6

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

141

2.35

4.98

2.6

2.4

—

Panic disorder

160

2.26

4.96

2.4

2.6

—

Other and unspecified follicular disorders

3.69

4.93

2.5

3.1

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

4.09

4.90

4.2

2.5

—

Thyroiditis, ILD-related definition

118

2.47

4.86

3.0

2.6

—

Visual disturbances

114

735

1.55

4.85

2.7

2.6

—

Other disorders of optic [2nd] nerve and visual pathways

3.00

4.83

3.1

2.5

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

11.73

4.81

5.8

2.4

—

Nonalcoholic steatohepatitis

11.73

4.81

3.8

1.7

—

Combined immunodeficiencies

9.18

4.80

2.3

3.0

—

Retinal breaks without detachment

222

2.03

4.80

3.1

2.7

—

Fracture of shoulder and upper arm

542

1.64

4.79

3.0

2.7

—

Other and unspecified epidermal thickening

4.62

4.79

4.1

2.3

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

5.04

4.78

1.9

2.8

—

Keratitis

543

1.64

4.77

3.2

2.6

—

Use of antiglaucoma preparations and miotics

2.75

4.77

2.7

2.3

—

Procreative management

436

1.67

4.76

2.8

—

Insomnia

196

2.10

4.75

2.3

2.5

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

3.28

4.74

1.5

3.0

—

Multiple myeloma and malignant plasma cell neoplasms

3.96

4.71

4.2

2.6

—

Benign neoplasm of ovary

145

2.28

4.69

2.4

2.6

—

Ocular pain

2.72

4.67

3.2

2.9

—

Panniculitis affecting regions of neck and back

3.71

4.65

2.1

2.8

—

Hypersplenism

14.60

4.62

4.3

2.2

—

Valvular operations

159

2.21

4.61

1.3

2.7

—

Reactive arthropathies, FINNGEN

2.91

4.60

2.4

3.0

—

Benign neoplasm: Oesophagus

14.20

4.59

2.7

4.6

—

Other/unspecified dorsalgia

585

1.60

4.57

3.2

2.9

—

Abnormal findings in nipple discharge synovial fluid wound secretions

8.30

4.57

2.0

1.6

—

Diagnoses used for exclusion with ILD

376

1.76

4.57

2.4

2.6

—

Cerebral aneurysm, nonruptured

110

2.47

4.54

2.7

2.6

—

Other disorders starting during childhood or adolecense, excluding more controls

4.44

4.54

2.9

3.2

—

Benign neoplasm: Conjunctiva

4.79

4.53

3.1

—

Tooth agenesis EXCLUDE clefts and syndromes

4.78

4.53

1.5

3.1

—

Artificial joint operation, meniscal resection

129

1263

0.68

4.53

2.5

2.9

—

Respiratory insufficiency

2.81

4.53

2.0

3.0

—

Speech and linguistic disorders, excluding more controls

3.09

4.52

2.3

2.7

—

Persistent mood disorders

241

1.96

4.52

3.1

2.6

—

L04AC Interleukin inhibitors

3.07

4.52

2.1

2.8

—

Dermatitis due to substances taken internally

3.07

4.51

3.3

2.6

—

Amiodarone users

135

2.31

4.51

2.2

2.5

—

Phobic anxiety disorders

135

2.30

4.50

2.5

2.6

—

HSIL lesion of the cervix uteri, vagina or vulva

214

2.01

4.49

2.7

2.8

—

Other and unspecified glaucoma

2.87

4.49

4.3

2.1

—

Emergency coronary revascularization (for ACS)

141

689

1.47

4.48

2.4

2.8

—

Disorders of conjunctiva

199

1211

1.38

4.48

2.7

2.8

—

Arthropathies

239

898

1.36

4.48

2.7

2.9

—

Impacted teeth

186

2.06

4.47

3.3

2.7

—

Other epidermal thickening

3.43

4.47

3.5

2.4

—

Benign neoplasm: Pancreas

4.04

4.44

2.2

2.7

—

Fitting and adjustment of other devices

304

1.81

4.44

2.8

2.6

—

Benign neoplasm: Stomach

130

2.32

4.42

4.1

2.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

138

926

1.46

4.42

2.8

2.9

—

Enlarged lymph nodes

162

2.17

4.42

2.3

2.7

—

Problems related to lifestyle

112

2.42

4.38

3.4

2.6

—

Poisoning by drugs, medicaments and biological substances

337

1.78

4.37

2.2

2.7

—

Other disorders of pigmentation

3.74

4.37

2.5

2.1

—

Adenocarcinoma and papillary adenocarcinoma of stomach

4.26

4.36

1.0

2.3

—

Benign neoplasm: Liver

7.57

4.36

3.4

2.8

—

Toxic effects of substances chiefly nonmedicinal as to source

150

2.21

4.36

3.1

2.8

—

Other diseases of gallbladder

3.52

4.33

2.6

1.9

—

Other disorders of conjunctiva

190

2.06

4.33

3.6

2.7

—

Follicular cysts of skin and subcutaneous tissue

245

1.92

4.33

2.6

2.8

—

Inflammatory diseases of female pelvic organs

125

631

1.49

4.32

3.0

2.8

—

Type of accident

420

1.69

4.32

3.7

2.6

—

Autoimmune hyperthyroidism

3.35

4.32

3.7

2.4

—

Benign neoplasm of eye and adnexa

2.66

4.32

2.5

2.7

—

Carcinoma in situ of oral cavity, oesophagus and stomach

12.05

4.31

2.3

2.2

—

Hodgkin lymphoma

4.58

4.31

2.3

3.3

—

Osteitis due to dental implant

12.01

4.30

5.1

2.2

—

Acute and subacute iridocyclitis

274

1.87

4.29

3.1

2.6

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

11.87

4.29

3.4

2.0

—

Pyogenic arthritis

2.79

4.28

2.0

3.0

—

Personal history of certain other diseases

11.76

4.28

2.1

1.3

—

Transport accidents

106

613

1.53

4.26

3.0

2.7

—

Somatoform disorder

198

2.03

4.26

2.9

2.6

—

Sequelae of cerebrovascular disease

429

1.64

4.23

2.2

2.6

—

Cyst of kidney

2.63

4.23

2.0

2.3

—

All dysplastic lesions of the cervix uteri

282

1.84

4.22

3.4

2.7

—

Ulcerative proctitis

2.85

4.22

3.5

3.0

—

Disorders of psychological development

105

2.39

4.21

2.3

2.8

—

Diffuse large B-cell lymphoma

3.16

4.21

2.5

2.6

—

Pneumonia derived septicemia

3.64

4.21

2.8

2.6

—

Carcinoma in situ of skin of ear and external auricular canal

7.04

4.18

1.7

2.0

—

N06DA Anticholinesterases

338

0.36

4.15

1.8

2.3

—

Use of anticholinesterases

338

0.36

4.15

1.8

2.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

328

1.77

4.15

2.1

2.8

—

Sleep disorders (combined)

251

1248

1.32

4.15

2.6

2.9

—

Malignant neoplasm of kidney, except renal pelvis

109

2.40

4.14

2.3

2.7

—

Benign neoplasm: Skin of other and unspecified parts of face

2.54

4.12

3.0

2.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

127

706

1.47

4.11

2.8

—

Superficial injury of abdomen, lower back and pelvis

194

2.02

4.11

2.8

2.6

—

Superficial injury of head

300

1.80

4.10

2.1

2.6

—

Hyphaema and other vascular disorders of iris and ciliary body

4.40

4.10

2.8

2.3

—

Lupus erythematosus

4.39

4.09

3.7

2.2

—

Melanocytic naevi of scalp and neck

4.39

4.09

3.3

2.9

—

Correction of physiology of bite - very demanding therapy visit

3.78

4.09

4.8

3.1

—

Other and unspecified disorders of vitreous body

611

1.55

4.06

2.8

2.6

—

Ingrowing nail

2.87

4.06

3.9

3.0

—

Certain conditions originating in the perinatal period

2.91

4.05

4.1

2.4

—

Injury of unspecified body region

2.57

4.05

3.0

2.6

—

Speech disturbances, not elsewhere classified

2.46

4.04

3.2

2.4

—

Malignant neoplasm of nasal cavity and sinuses

10.27

4.04

2.6

2.3

—

Postpartum haemorrhage

292

0.30

4.03

2.9

—

Mixed connective tissue disease

2.77

4.02

2.3

2.7

—

Rosacea

136

2.21

4.01

2.5

2.7

—

Malignant neoplasm of other and unspecified parts of biliary tract

6.54

4.00

2.0

1.7

—

Neurological diseases

226

849

1.34

4.00

2.5

3.0

—

Open wound of ankle and foot

130

2.24

3.98

3.4

3.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

130

2.24

3.98

2.9

2.4

—

Pacemaker

433

1.64

3.97

1.7

2.5

—

Anogenital herpesviral [herpes simplex] infection

2.82

3.95

3.6

2.6

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

455

1.63

3.93

3.6

2.6

—

Other diseases of oesophagus

106

2.37

3.89

3.1

2.4

—

Poor fetal growth

106

2.36

3.89

2.8

2.9

—

Acute gastritis

2.64

3.89

3.1

2.3

—

Benign neoplasm: Skin of scalp and neck

4.20

3.89

2.0

2.8

—

Drug-induced systemic lupus erythematosus

7.48

3.89

1.5

1.6

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.19

3.89

2.9

—

Other diseases of blood and blood-forming organs

2.57

3.88

3.2

2.6

—

Other and unspecified paralytic syndromes

7.37

3.87

2.7

1.5

—

Otitis externa

306

1.77

3.86

2.7

2.5

—

Amenorrhoea

2.78

3.85

2.4

3.0

—

Arthropathy in ulcerative colitis

6.09

3.83

2.8

2.7

—

Toxic encephalopathy

12.89

3.83

7.8

2.0

—

HSIL lesion of the vulva

6.07

3.83

2.6

2.2

—

Nonsuppurative otitis media

232

1.83

3.82

2.8

2.6

—

Asthma, hospital admissions , main diagnosis only

197

1318

1.34

3.82

2.5

2.9

—

Pure hyperglyceridaemia

6.05

3.82

2.4

3.0

—

Benign neoplasm: Liver/bile ducts

6.05

3.82

3.4

2.7

—

Benign neoplasm of middle ear and respiratory system

101

2.39

3.81

2.7

2.6

—

Injury of intra-abdominal organs

3.83

3.81

3.5

3.1

—

Pediculosis, acariasis and other infestations

2.61

3.80

2.7

3.2

—

Diseases of the ear and mastoid process

305

1210

1.28

3.80

2.8

2.9

—

Angina pectoris

150

720

1.41

3.80

2.0

3.0

—

Common variable immunodeficiency

12.28

3.78

2.5

1.4

—

Emotional disorders starting during childhood or adolecense, excluding more controls

4.09

3.77

1.9

2.8

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

3.36

3.76

2.6

—

Unspecified misadventure during surgical and medical care

2.74

3.75

2.9

2.6

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.74

3.75

2.4

2.5

—

Disorders of continuity of bone

108

2.32

3.75

2.6

—

Voice disturbances

354

1.70

3.74

2.5

2.6

—

Other disorders of bladder

154

2.09

3.71

2.2

2.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.45

3.71

2.8

2.2

—

Benign neoplasm: Rectosigmoid junction

3.02

3.69

3.7

2.5

—

Gonarthrosis, primary, with knee surgery

816

0.61

3.68

2.2

2.7

—

Other acute viral hepatitis

5.72

3.67

2.6

3.6

—

Undetermined asthma, excluding more controls

109

2.30

3.67

2.6

2.9

—

Nail disorders

103

2.34

3.66

3.5

2.8

—

Primary angle-closure glaucoma

3.13

3.65

2.3

2.4

—

Toxic effect of ethanol

3.13

3.65

3.0

3.4

—

Herpesviral [herpes simplex] infections

142

2.12

3.64

3.4

2.5

—

ILD, hospital admissions 1, main diag only

169

2.02

3.63

2.8

2.5

—

Other inflammation of eyelid

169

2.02

3.63

2.5

2.7

—

Pyothorax

2.88

3.63

3.2

2.5

—

Open bite

3.26

3.62

2.4

3.0

—

Lymphoid leukaemia

3.26

3.62

2.1

2.6

—

Pneumococcal septicemia

3.45

3.62

2.8

2.7

—

Ectropion of eyelid

3.45

3.62

1.8

2.3

—

Coeliac disease

149

2.09

3.62

4.3

2.6

—

Later onset COPD

284

1.69

3.61

2.0

2.1

—

Cerebral palsy and other paralytic syndromes

136

2.14

3.60

2.0

2.7

—

Nontraumatic intracranial haemmorrhage

247

1.83

3.59

2.6

2.7

—

Carcinoma in situ of oral cavity, oesophagus and stomach

8.02

3.59

2.3

1.7

—

Benign neoplasm: Rectum

262

1.80

3.58

3.1

2.7

—

Other forms of systemic lupus erythematosus

7.93

3.57

2.9

3.0

—

Secondary thrombocytopenia

7.89

3.57

3.9

1.8

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

7.89

3.57

2.0

1.6

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

7.84

3.56

2.0

1.6

—

L01XE Protein kinase inhibitors

2.66

3.56

3.4

2.4

—

Entropion and trichiasis of eyelid

2.45

3.54

2.0

2.1

—

Other congenital malformations

2.51

3.53

2.0

2.7

—

Concussion

115

689

1.45

3.53

2.9

—

Agoraphobia

3.87

3.52

3.4

3.0

—

Superficial injury of ankle and foot

144

2.09

3.52

2.4

2.8

—

Benign neoplasm: Rectum, anus and anal canal

293

1.75

3.52

3.1

2.7

—

Benign neoplasm: Liver

5.34

3.51

3.4

2.6

—

Otorrhagia

10.23

3.51

2.8

1.8

—

Late syphilis

6.24

3.51

3.6

3.2

—

Subjective visual disturbances

323

1.71

3.51

2.3

2.7

—

HSIL lesion of the vagina

6.24

3.51

3.6

3.2

—

Personal history of medical treatment

10.16

3.51

4.2

1.3

—

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

10.14

3.51

1.0

1.8

—

Leiomyoma of uterus

302

1.57

3.50

2.9

—

Postpartum hemorraghe, all women as controls

307

0.32

3.50

2.9

2.8

—

Oesophagitis

2.71

3.49

3.9

2.5

—

Fracture of foot, except ankle

354

1.67

3.48

3.4

2.7

—

Aortic aneurysm

296

1.73

3.48

2.2

2.6

—

Non-follicular lymphoma, hilmo, excluding all cancers

2.37

3.48

2.4

2.3

—

Benign neoplasm of major salivary glands

2.37

3.48

3.7

2.5

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.42

3.47

2.4

2.9

—

Polycystic ovarian syndrome, consortium definition

142

612

1.40

3.46

2.8

—

Other follicular disorders

2.54

3.46

2.4

3.0

—

Irritable bowel syndrome

325

1.70

3.44

2.6

—

Urticaria and erythema

519

1.54

3.44

2.7

—

Lung diseases due to external agents

166

1.99

3.43

2.7

2.4

—

Disorders of the thyroid gland

231

1167

1.29

3.41

2.7

2.8

—

Degeneration of macula and posterior pole

100

559

1.48

3.40

2.6

—

Episodal and paroxysmal disorders

278

1122

1.27

3.40

2.7

2.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

216

1093

1.31

3.40

2.7

2.8

—

Conjunctivitis

170

1104

1.34

3.39

2.5

2.8

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

2.67

3.39

1.5

3.0

—

Poisoning by medicine

304

1.71

3.39

1.9

2.7

—

Selective deficiency of immunoglobulin G [IgG] subclasses

7.16

3.38

3.1

3.0

—

Lichen simplex chronicus and prurigo

2.58

3.38

2.7

2.6

—

Traction detachment of retina

7.13

3.38

2.9

1.6

—

Other prurigo

7.10

3.37

1.7

—

Cholera

3.11

3.37

3.2

2.2

—

Hyperkinetic disorders, excluding more controls

2.58

3.37

3.8

2.9

—

Hypothyroidism, other/unspecified

212

1072

1.31

3.36

2.7

2.8

—

Left hemicolectomy

3.74

3.36

1.9

2.0

—

Macular cyst

3.74

3.36

2.6

—

Melanoma in situ

3.72

3.35

1.9

2.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

147

2.05

3.35

3.5

2.8

—

Other and unspecified immunodeficiencies with predominantly antibody defects

5.80

3.35

2.5

3.4

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

3.26

3.34

2.0

2.4

—

Asthma mixed form (mode)

3.25

3.34

2.3

3.2

—

Unspecific neurodegenerative disorder

374

0.50

3.34

2.6

2.3

—

severe traumatic brain injury, does not include concussion

313

1.70

3.33

3.3

2.6

—

Bell's palsy

161

1.99

3.33

1.9

2.9

—

Intracranial injury

132

918

1.39

3.33

3.2

2.6

—

Aortic valve malfunction, age under 60 years

141

2.07

3.31

3.6

2.8

—

Biological medication for rheuma

218

1.84

3.30

2.6

2.7

—

Contusion of other and unspecified parts of foot

2.93

3.30

2.3

3.5

—

Specific development disorders of speech and language

2.94

3.29

2.3

2.6

—

Other specified/unspecified bacterial intestinal infections

2.55

3.29

3.0

2.3

—

Other disorders starting during childhood or adolescence

3.42

3.29

2.9

3.3

—

LSIL lesion of the cervix uteri

102

2.26

3.28

4.0

2.5

—

Dorsopathies

259

1037

1.28

3.28

2.9

—

Disorders of optic nerve and visual pathways

115

2.18

3.28

3.1

2.5

—

Injuries to the elbow and forearm

161

1083

1.34

3.27

3.0

2.8

—

Other congenital malformations of intestine

8.71

3.27

6.0

3.3

—

Disorders of iron metabolism

8.66

3.27

4.0

3.1

—

Hordeolum and other deep inflammation of eyelid

2.79

3.25

2.8

2.6

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Magnesium Ionized [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS